These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8647768)

  • 1. Efficacy and safety of teicoplanin in infections caused by methicillin-resistant Staphylococcus aureus.
    Pachon J; Prados D; Palomino J; Cantos A; Cisneros JM; Vaquero F
    J Antimicrob Chemother; 1996 Jan; 37(1):197-200. PubMed ID: 8647768
    [No Abstract]   [Full Text] [Related]  

  • 2. The use and therapeutic drug monitoring of teicoplanin in the UK.
    Darley ES; MacGowan AP
    Clin Microbiol Infect; 2004 Jan; 10(1):62-9. PubMed ID: 14706088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.
    Elsaghier AA; Aucken HM; Hamilton-Miller JM; Shaw S; Kibbler CC
    J Antimicrob Chemother; 2002 Feb; 49(2):423-4. PubMed ID: 11815594
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    Carter MK; Ebers VA; Younes BK; Lacy MK
    Ann Pharmacother; 2006 Sep; 40(9):1693-5. PubMed ID: 16896018
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic antibiotic treatment of skin, skin structure, and soft tissue infections in the outpatient setting.
    Jones H
    Adv Skin Wound Care; 2012 Mar; 25(3):132-40; quiz 141-2. PubMed ID: 22343601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Daum RS
    N Engl J Med; 2007 Jul; 357(4):380-90. PubMed ID: 17652653
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergency department management of community-acquired methicillin-resistant Staphylococcus aureus.
    Kilbane BJ; Reynolds SL
    Pediatr Emerg Care; 2008 Feb; 24(2):109-14; quiz 115-7. PubMed ID: 18277849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dalbavancin in the treatment of skin and soft tissues infection].
    Candela Fajardo A; Urbieta Sanz E; Gallego Muñoz C
    Farm Hosp; 2017 Sep; 41(5):642-643. PubMed ID: 28847256
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Ruhe JJ; Menon A
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3298-303. PubMed ID: 17576834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antibiotics in the management of acute bacterial skin and skin structure infections.
    Gleghorn K; Grimshaw E; Kelly EK
    Skin Therapy Lett; 2015; 20(5):7-9. PubMed ID: 26382907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing methicillin-resistant Staphylococcus aureus in hospital: the balance of risk.
    Stone SP
    Age Ageing; 1997 May; 26(3):165-8. PubMed ID: 9223709
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN; Shively EH; Polk HC
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin in the treatment of skin and soft tissue infections.
    Turpin PJ; Taylor GP; Logan MN; Wood MJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dalbavancin for the Treatment of Complicated Gram-Positive Skin and Soft Tissue Infections.
    Petrakis V; Panagopoulos P; Papanas N
    Int J Low Extrem Wounds; 2020 Sep; 19(3):236-241. PubMed ID: 32500744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.
    Souli M; Pontikis K; Chryssouli Z; Galani I; Giamarellou H
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):760-2. PubMed ID: 16283218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
    Selva O'Callaghan A; San José Laporte A; Almirante Gragera B; Vilardell Tarrés M
    Med Clin (Barc); 1998 May; 110(17):678. PubMed ID: 9656216
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections.
    Quist SR; Fierlbeck G; Seaton RA; Loeffler J; Chaves RL
    Int J Antimicrob Agents; 2012 Jan; 39(1):90-1. PubMed ID: 21982144
    [No Abstract]   [Full Text] [Related]  

  • 20. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.